Results 221 to 230 of about 52,334 (267)
Some of the next articles are maybe not open access.

von Willebrand factor to the rescue

Blood, 2009
Abstractvon Willebrand factor (VWF) is a large multimeric adhesive glycoprotein with complex roles in thrombosis and hemostasis. Abnormalities in VWF give rise to a variety of bleeding complications, known as von Willebrand disease (VWD), the most common inherited bleeding disorder in humans.
Simon F, De Meyer   +2 more
openaire   +2 more sources

Platelet von Willebrand Factor

Mayo Clinic Proceedings, 1991
von Willebrand factor (vWF) circulates in the blood in two distinct compartments. One, plasma vWF, is synthesized and released from endothelial cells; the second, synthesized by megakaryocytes, circulates in platelets primarily stored in the alpha granules.
H R, Gralnick   +6 more
openaire   +2 more sources

von Willebrand's factor and von Willebrand's disease.

Current opinion in hematology, 1997
von Willebrand's factor is required for platelet adhesion to subendothelium, and for normal factor VIII survival in the circulation. These functions require the assembly of von Willebrand's factor into multimers that exhibit properly regulated binding to platelet glycoprotein lb. Recent studies suggest that the propeptide of von Willebrand's factor may
T, Matsushita, Z, Dong, J E, Sadler
openaire   +1 more source

[Von Willebrand factor and Von Willebrand disease].

Nederlands tijdschrift voor geneeskunde, 2014
Von Willebrand factor (VWF) is a multimeric adhesive protein that binds platelets to exposed subendothelium and carries factor VIII in the circulation. VWD is classified into three major subtypes, distinguished by a quantitative deficiency of VWF (type 1: partial deficiency; type 3: complete deficiency) or qualitative defects of VWF (type 2A, 2B, 2M ...
Paul W M, Verhezen   +2 more
openaire   +1 more source

von Willebrand factor and von Willebrand disease.

Blood, 1987
Progress has occurred in the past several years in the understanding of the structure and function of von Willebrand factor (vWF). This multimeric glycoprotein exhibits a dual role, that of mediating platelet adhesion and aggregation onto thrombogenic surfaces, and that of functioning as carrier in plasma for the factor VIII procoagulant protein.
Z M, Ruggeri, T S, Zimmerman
openaire   +1 more source

Factor VIII and von Willebrand Factor

Thrombosis and Haemostasis, 1998
IntroducationFactor VIII and von Willebrand factor are plasma glycoproteins whose deficiency or structural defects cause hemophilia A and von Willebrand disease, respectively (1). These diseases are the most common inherited bleeding disorders of man. Factor VIII and vWF are synthesized by different cell types and circulate in plasma as a tightly bound
Vlot, A.J.   +3 more
openaire   +3 more sources

von Willebrand factor and von Willebrand disease.

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2017
von Willebrand factor (VWF) has two major roles in hemostasis, as a form of molecular glue which functions in platelet plug formation and as a protective transporter for coagulation factor VIII (FVIII). VWF shows a multimeric chain structure composed of 270 kDa subunits containing binding domains for FVIII, platelet and collagens. Biosynthesis, storage,
Taei, Matsui, Jiharu, Hamako
openaire   +1 more source

Von Willebrand factor processing

Hämostaseologie, 2017
SummaryVon Willebrand factor (VWF) is a multimeric glycoprotein essential for primary haemostasis that is produced only in endothelial cells and megakaryocytes. Key to VWF’s function in recruitment of platelets to the site of vascular injury is its multimeric structure.
openaire   +2 more sources

Von Willebrand factor multimer patterns in von Willebrand's disease

British Journal of Haematology, 1983
Summary. The von Willebrand factor antigen (factor VIII‐related antigen, VIIIR:Ag) multimer pattern has been analysed by SDS‐agarose electrophoresis of plasmas from 116 patients (47 families) with von Willebrand's disease. In addition to previously recognized patterns, a subclassification was established between plasmas that had a type Ia pattern ...
L W, Hoyer   +5 more
openaire   +2 more sources

Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease

Blood Coagulation & Fibrinolysis, 2009
Therapy for von Willebrand disease (VWD) aims to restore the hemostatic function conferred by von Willebrand factor (VWF), which facilitates platelet adhesion and aggregation, and serves to increase potentially low coagulation factor VIII (FVIII) in plasma. In patients unresponsive to desmopressin (DDAVP), the preferred treatment is with plasma-derived
Javier, Batlle   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy